Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 6166 AL 6180

Targeting shelterin proteins for cancer therapy

Brankiewicz-Kopcinska W, Kallingal A, Krzemieniecki R, Baginski M.

Drug Discov Today. 2024 Aug;29(8):104056. doi: 10.1016/j.drudis.2024.104056. Epub 2024 Jun 4.

Long-Term Nicotinamide Riboside Use Improves Coordination and Eye Movements in Ataxia Telangiectasia

Presterud R, Deng WH, Wennerström AB, Burgers T, Gajera B, Mattsson K, Solberg A, Fang EF, Nieminen AI, Stray-Pedersen A, Nilsen H.

Mov Disord. 2024 Feb;39(2):360-369. doi: 10.1002/mds.29645. Epub 2023 Oct 29.

Skeletal Muscle Involvement in Friedreich Ataxia

Indelicato E, Wanschitz J, Löscher W, Boesch S.

Int J Mol Sci. 2024 Sep 13;25(18):9915. doi: 10.3390/ijms25189915.

Tremor in Spinocerebellar Ataxia: A Scoping Review

Mukherjee A, Pandey S.

Tremor Other Hyperkinet Mov (N Y). 2024 Jun 20;14:31. doi: 10.5334/tohm.911. eCollection 2024.

Effects and safety of transcranial direct current stimulation on multiple health outcomes: an umbrella review of randomized clinical trials

Kang J, Lee H, Yu S, Lee M, Kim HJ, Kwon R, Kim S, Fond G, Boyer L, Rahmati M, Koyanagi A, Smith L, Nehs CJ, Kim MS, Sánchez GFL, Dragioti E, Kim T, Yon DK.

Mol Psychiatry. 2024 Dec;29(12):3789-3801. doi: 10.1038/s41380-024-02624-3. Epub 2024 May 30.

Qualitative Study of the Patient Experience with Venglustat for Gaucher Disease Type 3 in a Phase 2 Open-Label, Multicenter, Multinational Study (LEAP)

Schiffmann R, Mengel E, Wallace M, Rochmann C, Turnbull J, Krupnick R, Gwaltney C, Pulikottil-Jacob R, Batsu I, Zheng R, Hamed A.

Adv Ther. 2024 Jul;41(7):2907-2923. doi: 10.1007/s12325-024-02881-2. Epub 2024 May 27.

Patient-Relevant Digital-Motor Outcomes for Clinical Trials in Hereditary Spastic Paraplegia Type 7: A Multicenter PROSPAX Study

Beichert L, Seemann J, Kessler C, Traschütz A, Müller D, Dillmann-Jehn K, Ricca I, Satolli S, Basak NA, Coarelli G, Timmann D, Gagnon C, van de Warrenburg BPC; PROSPAX Consortium; Ilg W, Synofzik M, Schüle R.

Neurology. 2024 Dec 24;103(12):e209887. doi: 10.1212/WNL.0000000000209887. Epub 2024 Dec 2.

Therapeutic Biomarkers in Friedreich's Ataxia: a Systematic Review and Meta-analysis

Gavriilaki M, Chatzikyriakou E, Moschou M, Arnaoutoglou M, Sakellari I, Kimiskidis VK.

Cerebellum. 2024 Jun;23(3):1184-1203. doi: 10.1007/s12311-023-01621-6. Epub 2023 Oct 27.

Efficacy and safety of N-acetyl-L-leucine in patients with ataxia telangiectasia: A randomized, double-blind, placebo-controlled, crossover clinical trial

Beyraghi-Tousi M, Sahebkar A, Houra M, Sarvghadi P, Jamialahmadi T, Bagheri R, Tavallaie S, Gumpricht E, Saberi-Karimian M.

Eur J Paediatr Neurol. 2024 May;50:57-63. doi: 10.1016/j.ejpn.2024.04.009. Epub 2024 Apr 22.

Gait ataxia in alcohol use disorder: A systematic review

Mistarz N, Canfield L, Nielsen DG, Skøt L, Mellentin AI.

Psychol Addict Behav. 2024 Jun;38(4):507-517. doi: 10.1037/adb0000958. Epub 2023 Sep 28.

Pioglitazone as a Possible Treatment for Ataxia-Telangiectasia

Shackelford R.

Biomolecules. 2024 Oct 8;14(10):1264. doi: 10.3390/biom14101264.

Clinical characteristics of BRAT1-related disease: a systematic literature review

Kong W, Cao X, Lu C.

Acta Neurol Belg. 2024 Aug;124(4):1281-1288. doi: 10.1007/s13760-024-02507-y. Epub 2024 Apr 12.

Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

Zielen S, Crawford T, Benatti L, Magnani M, Kieslich M, Ryan M, Meyts I, Gulati S, Borgohain R, Yadav R, Pal P, Hegde A, Kumar S, Venkateswar A, Udani V, Vinayan KP, Nissenkorn A, Fazzi E, Leuzzi V, Stray-Pedersen A, Pietrucha B, Pascual SI, Gouider R, Koenig MK, Wu S, Perlman S, Thye D, Janhofer G, Horn B, Whitehouse W, Lederman H.

Lancet Neurol. 2024 Sep;23(9):871-882. doi: 10.1016/S1474-4422(24)00220-5.

Evaluating mFARS in pediatric Friedreich's ataxia: Insights from the FACHILD study

Rummey C, Perlman S, Subramony SH, Farmer J, Lynch DR.

Ann Clin Transl Neurol. 2024 May;11(5):1290-1300. doi: 10.1002/acn3.52057. Epub 2024 Mar 31.

First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors

Yap TA, Tolcher AW, Plummer R, Mukker JK, Enderlin M, Hicking C, Grombacher T, Locatelli G, Szucs Z, Gounaris I, de Bono JS.

Clin Cancer Res. 2024 May 15;30(10):2057-2067. doi: 10.1158/1078-0432.CCR-23-2409.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias